AIMS and OBJECTIVES
Access to effective antimicrobials is crucial for treating infections in Canadians. However, some essential drugs are unavailable because they are not approved for use in Canada. The AMMI Canada Antimicrobial Access Interest Group (AAIG) aims to improve access to these critical antimicrobials.
Members of the interest group bring expertise in infectious diseases, medical microbiology, pharmacotherapy, healthcare delivery and health services research. The group aims to share knowledge and collaborate with clinicians, prescribers, pharmacists, researchers and public health authorities.
The group’s overall objective: to ensure Canadians have access to these vital antimicrobials when needed, by addressing and reducing barriers to their availability.
Should you wish to be added to the dedicated distribution list for the Antimicrobial Access Interest Group, please contact riccarda@ammi.ca
Approval for Future Use of Last-Resort Antibiotics through Health Canada’s Special Access Program
Speakers: Kevin Afra, Angus Kinkade, Cesilia Nishi
WELCOME TO THE MEMBER ONLY SECTION
If you do not have a membership and require one, please request access.